Key result
Phenylephrine infusion (increasing systolic blood pressure by 20-30 mmHg) decreased time domain measures and high-frequency power, indicating HRV does not reliably measure parasympathetic tone.
Why the study?
Does parasympathetic stimulation via phenylephrine infusion alter heart rate variability parameters in normal subjects?
Does parasympathetic stimulation via phenylephrine infusion alter heart rate variability parameters in normal subjects?
Heart rate variability parameters traditionally associated with parasympathetic tone may not reliably measure it, as they decrease with baroreflex parasympathetic stimulation.
No takes yet. Share an insight, caveat, or question.
HRV parameters should not guide parasympathetic assessment; challenges consensus on traditional indexes and leaves validation of alternatives open.
Goldberger et al. (1994) studied Healthy subjects (n=10). Phenylephrine infusion and atropine vs. Baseline was evaluated on Heart rate variability (time and frequency domain parameters). Phenylephrine infusion (increasing systolic blood pressure by 20-30 mmHg) decreased time domain measures and high-frequency power, indicating HRV does not reliably measure parasympathetic tone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: